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Abstract. To address the question whether leukocyte
integrins are able to generate signals activating neutro-
phil functions, we investigated the capability of mAbs
against the common ß chain (CD18), or the distinct
a chains of CR3, LFA-1, or gp150/95, to activate neu-
trophil respiratory burst. These investigations were
performed with mAbs bound to protein A immobilized
to tissue culture polystyrene. Neutrophils plated in
wells coated with the anti-CD18 mAbs IB4 and 60.3
released H202 ; H202 release did not occur when neu-
trophils were plated in wells coated with an irrelevant,
isotype-matched mAb (OKDR), or with mAbs against
other molecules (CD16, ß2-microglobulin) expressed
on the neutrophil surface at the same density of CD18.
Four different mAbs, OKMI, OKM9, OKM10, 60.1,
which recognize distinct epitopes of CR3 were unable
to trigger H202 or 02 release from neutrophils. How-
ever, mAbs against LFA-1 or gpl50/95 triggered both
H202 and 02 release from neutrophils. Stimulation of
neutrophils respiratory burst by both anti-CD18, and
T
13E 02 subfamily of integrins is constituted by three
heterodimeric transmembrane molecules that are all
expressed by circulating leukocytes (9, 35). Expres-
sion of the individual members of the family, which are re-
ferred to as LFA-1 (CDlla/CD18), CR3 (CDI lb/CDl8), and
gp150/95 (CDllc/CD18), varies in different cell types (35),
neutrophils displaying the unique phenotype of expressing
all the three leukocyte integrins, and CR3 at a higher density
than LFA-1 and gp150/95 (6).
The peculiarity of CR3 is that to recognize a wide array
of different molecules, a property that underlies its involve-
ment in adhesion of phagocytes to endothelium (11, 17) and
fibrinogen (45), uptake of parasites (8, 29-33, 42, 44, 46),
and activation of the coagulation cascade (1, 2) . Also, the
recognition repertoire of both LFA1 and gp150/95 indicate
that these molecules certainly play a role in mediating neu-
trophil functions in the inflammatory site. LFA-1 has been
established as the counter-receptor for ICAM-1 and ICAM-2
expressed by endothelial cells (19, 37). Recent data showed
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anti-LEA-1 or gp150/95 mAbs was totally inhibited by
the microfilaments disrupting agent, cytochalasin B,
and by a permeable cAMP analogue. While the capa-
bility to activate neutrophil respiratory burst was re-
stricted to anti-LEA-1 and gp150/95 mAbs, we ob-
served that mAbs against all members of leukocyte
integrins, including CR3, were able to trigger neutro-
phil spreading. These findings indicate that, in neutro-
phils, all three leukocyte integrins can generate signals
activating spreading, but only LFA1 and gp150/95 can
generate signals involved in activation of the respira-
tory burst. This observation can be relevant to under-
stand the mechanisms responsible for the activation of
neutrophil respiratory burst by tumor necrosis factor-
alpha, which has been shown to be strictly dependent
on expression of leukocyte integrins (Nathan, C., S.
Srimal, C. Farber, E. Sanchez, L. Kabbash, A. Asch,
J. Gailit, and S. Wright. 1989. J. Cell Biol. 109 :
1341-1349) .
that gpl50/95 also binds to a molecule induced on en-
dothelial cellsby IL-1 or endotoxin (36) . Furthermore, both
molecules, together with CR3, act as an endotoxin receptor
(42), and bind Histoplasma capsulatum (7, 26). gp150/95
has been reported to bind fibrinogen (18) and possibly ON
(14, 21).
Whether ligation of the three leukocyte integrins ex-
pressed by neutrophils is able to deliver a signal able to acti-
vate selective neutrophil functions is unknown. Studies per-
formed on CR3 have indicated that this molecule, and hence
possibly also LFA1 and gpl50/95, acts mainly as an adhe-
sion molecule that does not trigger signals activating selec-
tive cell functions such as phagocytosis, release oftoxic oxy-
gen molecules, or secretion (25, 34, 40, 47). However, early
studies on mononuclear phagocytes (reviewed in reference
41), subsequently extended to neutrophils (43), showed that
uptake of Obi-coated erythrocytes can be converted in a
true phagocytic event. Furthermore, it has been demon-
strated that the generation of hydrogen peroxide by adherent
1007neutrophils in response to tumour necrosis factor-alpha
(TNF)' is strictly dependent on expression of leukocyte
integrins (24).
Studies on the role of leukocyte integrins in generation of
hydrogen peroxide in response to TNF did not allow one to
conclude whether ligation of leukocyte integrins renders
neutrophils responsive to TNF or TNF activates these mole-
cules to generate a signal able to activate the respiratory
burst (16, 22, 24). We therefore decided to address the ques-
tion whether CR3, LFA-1, and gp150/95 per se are able to
activate selective neutrophil functions by studying the effects
of mAbs directed against distinct epitopes of the common ß
chain or the a chain of individual members of the family.
We show in this paper that two mAbs directed against the
ß chain of leukocyte integrins trigger neutrophil respiratory
burst . Studies with mAbs directed against the a chain of
CR3, LFA-1, and gp150/95 allowed us to establish that only
anti-LFA-1 and gp150/95 mAbs are able to trigger neutrophil
respiratory burst while mAbs directed against distinct epi-
topes of the CR3 a chain have no effect. Studies with inhibi-
tors enabled us to demonstrate that signals generated by
LFA-1 and gp150/95 require an intact cytoskeleton and are
negatively regulated by an elevation of intracellular cAMP.
Materials andMethods
BindingofmAbsto Protein A Immobilizedto Plastic
The list of mAbs used for these studies is reported in Table I. mAbs were
kindly donatedby Dr. S. D. Wright, The Rockefeller University (New York,
NY) (1114), Dr. P. Rao, Robert Wood Johnson Pharmaceutical Research In-
stitute (Raritan, NJ) (OKMI, OKM9, OKM10), Dr. E. Plata, Oncogene
(Seattle, WA) (60.3, 60.1), Dr. G. Trinchieri and B. Perussia, Wistar Insti-
tute for Anatomy and Cell Biology (Philadelphia, PA) (BB.MI, Bó6.6,
3G8), AIDS Research and Reference Reagent Program, National Institutes
ofHealth (Bethesda, MD) (SIM 4), or obtained from commercial sources
(see Table I). All themAbs were used as purified preparations andimmobi-
lized to tissue culture plastic coated with protein A, purified from culture
medium of a protein A secreting Staphylococcus aureus (Sigma Chemical
Co., St. Louis, MO), or protein G, purified from group C Streptococcus
(Sigma Chemical Co.). 96-well plates of tissue culture grade polystyrene
(Nunc, Roskilde, Denmark) were treated for 30 min at room T with 50,u]
of0.1 mg/ml poly-r.-lysine (Sigma Chemical Co.) in PBS, and, after wash-
ing with PBS, for 15 min at room T with 2 .5% EM grade glutaraldehyde
in PBS, as originally described by Michl et al. (20). 50 At protein A or pro-
tein G at 0.1 mg/ml in PBS were added to poly-r,-lysine-glutaraldehyde-
treated wellsandtheplatesleftat4°C for 5-8 h. Glutaraldehyde-freegroups
were quenched by overnight incubation with 2 mg/ml casein in PBS, and
after washing with PBS, 50 pl mAbs suspended, at different concentrations,
either in PBS or 1 M NaCI-50 mM Tris, pH 8, were added (see below for
further details). After incubation for 2-3 h at 4°C with the mAbs solutions
or PBS as control, plates were washed twice with PBS, incubated further
for 2 h with 50 pl FCS, and finally washed three times with PBS. All the
procedures described above were done with reagents diluted in endotoxin-
free water for clinical use and in sterile conditions. Triplicate wells were
prepared, as described, for assays of hydrogen peroxide (H202) or superox-
ide anion (OZ) release and another set, also in triplicate, for measuring
binding of mAbs. The last step of quenching of the wells with FCS, after
binding of the mAbs, was required to suppress the vigorous H202 release
which occurs upon interaction of neutrophils with plain polystyrene (22)
which was not suppressed by quenching with casein; previous studies
showed that suppression of this neutrophil response can be achieved only
with some serum or extracellular matrix proteins and not with albumin or
elastin (22). Preliminary experimentswereperformed todefine optimal and
reproducible conditions ofbinding. Comparisons were made between bind-
ing of the different mAbs to protein A or protein G in PBS, to protein A
1. Abbreviations used in this paper: CR3, complement receptor type 3;
ICAM, intercellular adhesion molecule; LFA, leukocyte function-associated
antigen; TNF, tumor necrosis factor.
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Table L mAbs Used in This Study
in different buffers (PBS versus 1 M NaCI-50 mM Tris, pH 8), and to pro-
tein A in PBS at different concentrations. We observed that binding to pro-
tein A compared to protein G varied, but somehow independently of the
theoretical expectancy on the basis of mAb subclasses, and that dilutions
of mAbs in different buffers did not affect the extent ofbinding to protein
A. However, binding to protein A of mAbs of different subclasses could be
optimized by using different concentrations of mAbs. On the basis ofthese
experiments we routinely used PBS solutions of 10, 15, or 50 Ag/ml for
mAbs of the IgG2a, IgG2b or IgG1 subclass, respectively. Comparison of
binding to mock-treated wells where protein A was not immobilized showed
that binding of the different mAbs used to casein-quenched poly-L-lysine-
glutaraldehyde-derivatized polystyrene was not above 25 % of the binding
to protein A. Binding of mAbs was detected by ELISA with HRRcon-
jugated goat anti-mouse Igs (Amersham International plc, Amersham, UK)
diluted 1/2,000 in PBS containing 1 mg/ml BSA, and revealed by using
o-phenylene-diamine as substrate. Absorbance was read at 492 run with an
automated microplate reader (model EL34; BioTec Instruments, Inc.,
Winooski, VT).
Binding ofmAbs toProteinA-Sepharose
orStaphylococcus aureus
25-50 ,u1 of packed protein A-Sepharose (Pharmacia LKB Biotechnology,
Uppsala, Sweden) were rotated for 1 h at 4°C in 500 At 0.15 M Na-
phosphate buffer, pH 8.0, containing 50 Ag 60.3, 60.1, OKMI or purified
mouse Igs. At the end of the incubation, beads were washed twice with the
above buffer and resuspended in a final volume of 100 pl; 80 jut of this sus-
pension were used to stimulate H202 release (see Fig. 2). 20 JAI Staphylo-
coccus aureus (Pansorbin, Calbiochem Co., San Diego, CA) were rotated
for 1 h at 4°C in 500 A1 PBS containing 40 pg purified mouse Igs or 1114,
and 2 mg/ml BSA. At the end ofthe incubation, bacteria were washed twice
with PBS and resuspended in 60 WI; 10 p,l ofthis suspension were used to
stimulate H202 release (see Fig. 2). Binding of mAbs to inununoadsor-
bents was controlled by SDS-PAGE analysis.
IsolationofNeutrophils andAssays ofH202
and OZ Release
Neutrophils were isolated frombully coats ofhealthy volunteers by dextran
sedimentation and centrifugation over Ficoll-Hypaque (Pharmacia LKB
Biotechnology) . Contaminating erythrocytes were lysed by hypotonic sa-
line, and then neutrophils washed with HBSS and finally resuspended in
HBSS containing 0.5 mM CaC12 and 5 mM glucose. All the above proce-
dures were done in sterile conditions and by using reagents prepared in
endotoxin-free water for clinical use. Wells coated with mAbs were filled
with 150 pl of Hanks'-CaC12-glucose containing 2 mM NaN3, 0.8 mM
homovanillic acid and 20 mg/ml HRP for assays of H202 release, or with
the same volume of Hanks'-CaC12-glucose containing 2 mM NaN3 and
100 AM ferricytochrome c for assays of 02 release. For assay of H202 re-
lease, plates were kept at 37°C in 95% air/5% C02 for 5 min and then
50 At of neutrophil suspensions of 4 x 106 cells/ml were added, and the
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mAb Subclass Specificity References/Sources
IB4 IgG2a CD18 44
60.3 IgG2a CD18 3
OKMI IgG2b CDllb 38
OKM9 IgGI CDllb 38
OKM10 IgG2b CDllb 38
60.1 IgGI CD11b 39
IOT16 IgGI CDlla Immunotech S.A.
IOMIIc IgGI CD11c Immunotech S.A.
OKDR IgG2a DR Ortho Diagnostic System
SIM4 IgGI CD4 AIDS Research and Reference
Reagent Program.
OKT4 IgG2b CD4 Ortho
B66.6 IgG1 CD4 28
3G8 IgG1 CD16 12
BB.M1 IgG2b ß2-microglobulin 5z
a.
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Figure 1. mAbs against CD18 trigger H202 release from neutro-
phils. (A) mAbs were boundto protein A-coated polystyrene plates
as described in Material and Methods; the indicated mAbs were
used at a concentration of 10 ug/ml. The mean results t SD of
three independent experiments are reported. (B) H202release was
assayed in the presence of 100 nM FMLP or 50 Ag/ml ConA in
polystyrene plates coated with protein A and mock-treated with
PBSinstead ofIBM or OKT4. One representative ofthree indepen-
dent experiments is reported. (C) H202 release was assayed in
polystyrene plates coated with protein Aor protein G. Mean results
t SD of threeindependent experiments are reported. (D) Binding
of 60.3 and OKT4 to protein A and protein G in the experiments
shown in C.
incubation prolongedfordifferent times in the same conditions. At the end
of theincubation, 1501íl were withdrawn from each well, diluted in 2 ml
of PBS, andread in a LS-5 Perkin Elmerluminescence spectrometer with
an excitation wavelength of 315 nm and an emission one of 425 nm. The
amounts of H202 produced were quantified from a standard curve done
with known amounts of H202 diluted in the same volume of the reaction
mixture described above and incubated in the conditions used for assays
with neutrophils. For the measurement of 02 release, plates were in-
cubated in an automated EL34 microplate reader (BioTec Instruments)
with thecompartment T setat 37eC.Absorbante wasrecorded every 5 min
and up to 90-120 min at wavelengths of 550 and 468 nm. Differences in
absorbante at thetwowavelengths were used to calculatenmol ofOZ-pro-
duced by using an extinction coefficient of 24.5 mM (4).
10-mm diameter glasscoverslips were placed in 24-well plates and coated
with different mAbs as above described fortissue culture plates. 1 x 106
neutrophils were plated on mAb-coated coverslips andafterincubation for
60 minat 37°C in 95% air/5 % CO2, fixed by addition of cold formalde-
hyde at a final concentration of 3.7%. After 30 min at room T, cells were
washed with PBSanddehydrated in alcohols. Afterclarification with ben-
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Figure 2. 60.3 bound to protein A-Sepharose and 1134 bound to
Staphylococcus aureus trigger H202 release from neutrophils. 0.5
x 106 neutrophils in 2 ml of the reaction mixture used to measure
H202 generation (see Materials and Methods) were maintained in
suspension by magnetic stirring in the cuvette of a LS-5 lumines-
cence spectrometer. Fluorescence changes were monitored before
and after addition of immunoadsorbents coated with different anti-
bodies.
zene, coverslips were mounted up side down on glass slides in Entelan.
Slides were analyzed at phase contrast with a Zeiss RA microscope
equipped with a Zeiss MC 63C photomicrograph's apparatus.
Results
mAbs against theß Chain(CD18)
ofLeukocyteIntegrins TlriggerH202Release
from Neutrophils
To addressthequestion whetherleukocyteintegrinscanacti-
vate neutrophil respiratory burst, we first tested the effects
ofthetwoanti-CD18mAbs, 60.3 and IBM. 60.3 andIN were
bound to protein A immobilized to plastic to enhance the
probability that the Ag-binding site of the mAbs was free to
interact with the CD18 molecule andto reduce theprobabil-
ity that mAbs could interact with neutrophil through Fc
receptors. Theprocedureused to bind mAbs ofdifferentsub-
classes to protein A is detailed in Materials and Methods.
As shownin Fig. 1, when neutrophils were plated in wells
in which 60.3 or IBM were boundto immobilized protein A,
they released H202 . H202 release was time-dependent, con-
tinued up to 120 min and then ceased (not shown). Similar
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Figure 3. mAbs against CD16 and ß2-microglobulin do nottrigger
H202 release from neutrophils. 60.3, BB.Ml, and 3G8 were bound
to protein A-coated polystyrene plates at concentration of 10, 15,
and 30 Ag/ml, respectively. Themean results f SD of three inde-
pendent experiments are reported.
results were obtained by assaying 02 generation (see, for
example, Fig. 6) . The isotype matched, IgG2a, anti-DR
mAb, OKDR (Fig. 1 A), or the IgG2b mAb, OKT4 (Fig. 1
B), did not trigger H202 release, thus excluding any possi-
blecontribution of an Fc-dependent stimulation. Incubation
of protein A-coated wells with 60.3 or IB4 at different con-
centrations showed that stimulation of neutrophil H202 de-
pended on the amount of immobilized mAbs (not shown); a
maximal effect was observed by treating protein A-coated
wells with 50 Al of a 10-Ag/ml solution, and this concentra-
tion was used in the experiments described below.
Interaction of neutrophils with immobilized anti-CD18
mAbs was accompanied by the release of quite elevated
Figure 4. mAbs against the achainofCR3 do nottrigger H202 re-
lease from neutrophils. Forbinding to protein Aor mock(casein)-
coated polystyrene plates, 60.3 wasused at 10 jAg/ml, OKMl at 15
,ug/ml, andSIM4 and OKM9 at 50,ug/ml. Themean results t SD
of three independent experiments are reported. Binding of mAbs
wasrevealed in ELISAwith HRP-conjugated goat anti-mouse Igs.
Bindingto protein A-coated wellsor to casein-coated wells(values
in parenthesis), in OD at 492 nm, was: 0.020 f 0.010 (0.018 f
0.010) for PBS; 0.529 t 134 (0.106 t 0.055) for SIM4; 0.538
t 0.069 (0.163 t 0.079) for 60.3; 0.550 f 0.122 (0.288 t 0.091)
for OKMI; and 0.449 f 0.168 (0.131 t 0.068) for OKM9.
C
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Figure 5. mAbs against LFA1 and gp150/95 trigger H202 release
from neutrophils. For binding to protein A-coated polystyrene
plates 60.3 was used at 10 Ag/ml andall theother mAbs at 50 lAgl
ml. The mean results f SD of three independent experiments are
reported . Bindingof mAbs wasrevealed as describedin Fig. 4; OD
at 492 nm were: 0.018 t 0.010 for PBS; 0.397 f 0.035 for OKT4;
0.410 f 0.050 for B66.6; 0.422 f 0.045 for 60.1; 0.386 t 0.042
for60.3; 0.394 f 0.041 forIOMI lc; and0.400 t 0.037 for 10T16.
amounts of H202. In the experiments presented in Fig. 1
(A), in assays, performed in parallel, with concentrations of
PMA (10 ng/ml) that were maximally stimulatory in ourex-
perimental conditions, the release of H202 reached a maxi-
mal level of 20.2 f 1.5 nmol. Therefore, release of H202
upon interaction with anti-CD18 mAbs reached 30-40% of
that triggeredby the most powerful stimulus of neutrophil re-
spiratory burst. As shown in Fig. 1 (B), optimal concentra-
tions of F-Met-Leu-Phe or Con A stimulated the production
of amounts of H202 comparable to those produced in re-
sponse to anti-CD18 mAbs. Fig. 1 (C) also shows that the
anti-CD18 mAb, 60.3, was effectiveeither ifimmobilized to
protein A or proteinG, thelower stimulation obtained when
60.3 was immobilized to protein G being due to the lower
extent of mAb binding (Fig. 1 D).
The capability of anti-CD18 mAbs to trigger H202 re-
lease from neutrophils was also investigated by an alternative
approach. As shownin Fig. 2, 60.3 andIB4boundto protein
A-Sepharose or Staphylococcus aureus, respectively, trig-
gered H202 release from neutrophils; neither mouse control
inununoglobulins, bound to both matrices, northe anti-CR3
mAbs 60.1 or OKMI, bound to protein A-Sepharose, had
any effect. The inability of anti-CR3 mAbs to trigger H202
release from neutrophils will be described in more detail in
the following sections.
Comparison oftheAbility ofmAbs against
CD18 andofmAbsagainstOtherSurfaceMolecules
to TriggerH202Releasefrom Neutrophils
The ability of anti-CDl8 mAbs to trigger H202 release
from neutrophils could depend on cross-linking ofthe CD18
molecule. Although mAbs have been widely used to identify
a surface molecule as able to trigger selective cell functions,
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one can not exclude that cross-linking of surface molecules
by mAbs also causes nonspecific effects, including recruit-
ment of other molecules able to generate activating signals .
As a first approach to demonstrate the selectivity of anti-
CD18 mAbs, we compared the capability of mAb 60.3 to
trigger H202 release with that of other mAbs against neu-
trophils surface molecules .
We selected mAbs to be investigated on the basis of pre-
liminary experiments on the extent of mAbs binding to the
neutrophil surface. Cytofluorographic analysis showed that
the anti-ß2 microglobulin mAb, BB.Ml, and the anti-FcyR-
III(CD16) n Ab, 3G8, bound to neutrophils to an extent com-
parable to 60.3 . Data of indirect immunofluorescence bind-
ing as mean channel fluorescence intensity in three indepen-
dent experiments were 610 f 84 for 60.3, 588 t 10 for
BB.Ml, and 672 f 106 for 3G8 .
Fig . 3 shows that while 60.3 bound to immobilized Protein
A triggered H20 2 release from neutrophils, BB.MI and 3G8
did not cause any increase of H 202 release above the back-
ground observed in wells coated with protein A and mock-
treated with PBS .
These observations demonstrated that the ability of anti-
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CD18 mAbs to trigger H202 release is selective and ligation
and/or cross-linking of two other surface molecules ex-
pressed on the surface at the same density are unable to trig-
ger neutrophil functions .
mAbs against the ci Chain ofCR3Are Unable
to 7lriggerH 202 Generation by Neutrophils
The evidence that anti-CD18 mAbs triggered H202 release
from neutrophils prompted studies on the effect of mAbs
against the a chain ofCR3 since this is themember of leuko-
cyte integrins expressed at the highest density on the neutro-
phil surface .
As shown in Fig. 2, experiments with the mAbs 60.1 and
OKMI, which recognize different epitopes of the CR3 a
chain, immobilized to protein A-Sepharose, already indi-
cated that anti-CR3 mAbs are unable to trigger H 202 re-
lease . Further experiments were performed with mAbs
bound to protein A immobilized to tissue culture plates .
As shown in Fig . 4, neither OKM1 nor OKM9 were able
to trigger H202 release from neutrophils . The lack of effect
of the two mAbs was not due to a decreased binding ofanti-
CR3 mAbs ; in fact, as reported in figure 4 legend, compara-
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neutrophils. For binding to protein
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Figure 7 . Stimulation of H202 release from neutrophils by anti-
CD18 and anti-LFA-1 and gp150/95 mAbs requires assembly ofmi-
crofilaments and is inhibited by a cAMP analogue. mAbs were
bound to protein A-coated polystyrene plates as described in the
legends to Figs. 4-6. Assays were performed as described in Mate-
rials and Methods in the presence of the indicated concentrations
of inhibitors. One representative of three experiments is reported.
ble amounts of the different mAbs were bound to immobi-
lized protein A.
In the experiments whose results are reported in Fig. 4,
we also included another control to demonstrate that trigger-
ing of H202 release from mAb 60.3 is due to interaction of
its Ag-binding site with CD18. In fact, immobilization of
mAb 60.3 to plastic at random, i.e., in the absence of protein
A did not cause any significant effect. The capabilities of
OKM1 and OKM9 or the irrelevant mAb SIM4 to trigger
H202 release were negligible either if immobilized through
the Fc fragment to protein A or to plastic at random.
Also the effects ofmAbs against other epitopes of the CR3
« chain were tested. As described in Figs. 5 and 6, neither
60.1 nor OKM10 had the capability to trigger H202 or 02
release, respectively.
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mAbsagainstthe «chain ofLFA1 andgp150/95
Trigger H202 and 02 ReleasefromNeutrophils
The evidence that anti-CD18 mAbs but not anti-CR3 mAbs
triggered H202 release, prompted studies to demonstrate
whether the effects of anti-CD18 mAbs depended on the liga-
tion ofLFA-1 and gp150/95, the other two members ofleuko-
cyte integrins expressed, albeit at low density, by neutro-
phils.
The results presented in Figs. 5 and 6 clearly show that
this is the case. As shown in Fig. 5, mAbs IOT16 and
IOMIlc, which are against the a chain of LFA-1 and
gp150/95, respectively, triggered H202 release with the
same efficiency of anti-CD18 mAbs. Again, an irrelevant,
isotype matched, IgG1 mAb (SIM4), and an isotype
matched, anti-CR3 mAb (60.1) had no effect. As shown in
the Fig. 5 legend, the different ability of anti-CR3 or anti-
LFA-1 and gp150/95 mAbs to trigger H202 release was not
due to a different extent ofbinding to immobilized protein A.
Fig. 6 shows kinetics of 02 release from neutrophils
plated in wells in which different mAbs had been bound to
protein A. Clearly, anti-CR3 mAbs recognizing different
epitopes of the a chain were unable to trigger 02 release.
Both anti-LFA-1 and anti gp150/95 mAbs were effective in
triggering 02 release.
TriggeringofH202Releasefrom Neutrophils
byAnti-CD18 andAnti-LFA1 andgp150195 mAbs
Requires Integrity ofMicrofilaments andIs Blocked
byElevationofIntracellular cAMP
Activation of the neutrophil capability to produce H202 and
02 shows differential sensitivity to various drugs on the
basis of the activating stimulus used. Recent studies on re-
lease of toxic oxygen molecules by neutrophils adherent to
biological surfaces in response to TNF have shown that this
type of stimulus displays an absolute sensitivity to the
microfilaments' disrupting agent cytochalasin B, and to ele-
vation of intracellular cAMP (16, 22, 23) .
As shown in Fig. 7, triggering of H202 release by anti-
CD18 and anti-LFA-1 and gp150/95 mAbs was completely
blocked by cytochalasin B and dibutyryl cAMP in the pres-
ence of 1 mM theophylline. As expected from well estab-
lished observations (see references 10, 23), in parallel ex-
periments (not shown), cytochalasip B enhanced the response
to F-Met-Leu-Phe, and dibutyryl cAMP did not affect the re-
sponse to phorbol esters.
Interaction ofNeutrophils withAntileukocyte
IntegrinsmAbs Causes CellSpreading
Fig. 8 and 9 show images of neutrophils plated on different
mAbs. It can be seen that on protein A alone, as well as on
an irrelevant mAb, cells appear rounded and simply settled
on the bottom of the wells. In these conditions, neutrophils
Figure 8. mAbs against CD18 and CR3 trigger neutrophil spreading. Glass coverslips were coated with protein A and used to bind: A
and B nil (PBS); C and D, SIM4; Eand F, 60.3; and G and H, OKMI. mAbs were used at the concentrations indicated in the legends
to Figs. 4-6. Bars, 10 /,m.Berton et al . Activation ofNeutrophil Respiratory Burst 02 /ntegrins
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1014can be easily detached from the bottom of the wells by
washing.
Upon settling on an anti-CDl8 mAb (Fig. 8, E and F),
neutrophils underwent a marked spreading; spread cells ap-
pear mainly rounded with some of them showing extended
pseudopods (Fig. 8 F).
As shown in Fig. 1 (G and H), the anti-CR3 mAb, OKMI,
also induced spreading. Also, mAbs against other epitopes
of the CR3 a chain, such as OKM9 and OKM10, had the
same effect (not shown). Fig. 9 shows that spreading also oc-
curred when neutrophils were plated in wells coated with
anti-LFA1 and anti-gp150/95 mAbs. On the basis ofwhat we
observed in the whole course of these studies, we believe that
the extent of spreading on anti-CD18 mAbs is more pro-
nounced than on anti-CR3, or anti-LFA-1 and gp150/95
mAbs; neutrophils spread on mAbs against distinct a chains
of leukocyte integrins were more rounded and showed less
elongated pseudopods (see Figs. 8 and 9).
These observations show that mAbs against all the three
members ofleukocyte integrins are able to trigger neutrophil
spreading. Thus, the capability of antileukocyte integrins
mAbs to trigger release of toxic oxygen molecules does not
correlate in a simple way with induction of spreading; anti-
CR3 mAbs generate signals able to activate cell spreading,
anti-LFA-1 and gp150/95 generate signals able to activate
both spreading and respiratory burst.
Discussion
By usingmAbs recognizing epitopes of the common ß chain
or the distinct a chains of leukocyte integrins, we have
demonstrated that ligation and/or cross-linking of LFA-1 and
gpl50/95, but not CR3, triggers signals activating neutrophil
respiratory burst. Several observations allow us to conclude
that the effects of anti-LFA-1 and gp150/95 mAbs are selec-
tive and due to binding of the Ag-binding site of the mAbs.
In fact, (a) irrelevant mAbs (SIM4, B66.6) matched for the
same subclass (IgGl) of the stimulatory anti-LFA-1 mAb,
IOT16, and anti-gpl50/95 mAb, IOM1lc, were unable to ac-
tivate neutrophil respiratory burst; (b) two anti-CR3 mAbs,
60.1 and OKM9, of the same subclass of the stimulatory
mAbs were also ineffective; (c) two mAbs, 1134 and 60.3,
recognizing different epitopes of the common ß chain of leu-
kocyte integrins were able to activate neutrophil respiratory
burst while either an irrelevant, isotype matched (IgG2a),
mAb, OKDR, or the anti-CR3 mAbs, OKM10 and OKMI,
of the IgG2b subclass, were ineffective; and (d) mAbs 3G8
and BB. Ml, against CD16 and ß2-microglobulin, respec-
tively, were unable to activate neutrophil respiratory burst.
The evidence that mAbs against epitopes of CR3 corre-
sponding to distinct binding sitesfor different ligands are un-
able to activate neutrophil respiratory burst is in agreement
with previous observations demonstrating that CR3 mediates
binding of C3bi-coated particles without triggering inges-
tion, secretion, and respiratory burst (25, 34, 40, 47).
Our results show that LFA-1 and gp150/95 are able to de-
liver signals responsible for the activation of neutrophil re-
spiratory burst. This observation is remarkable also in light
ofthe evidence that, compared to CR3, LFA1 and gp150/95
are expressed at a lower density on the neutrophil surface
(6) . To our knowledge, no study has been performed on the
capability of gp150/95 to trigger signals possibly involved in
activation of neutrophil or other leukocyte functions. How-
ever, evidence has been presented that anti-LFA-1 mAbs trig-
ger phosphoinositides turnover and cytoplasmic calcium
transients in lymphocytes subsets (27) .
Elegant experiments have recently demonstrated that the
cytoplasmic domain ofthe ß subunit of LFA-1 is essential for
the function of this molecule in adhesion and its activation
by phorbol esters (13). This observation does not contradict
our finding that ligation of CR3, which most of the ,ß chain
expressed by neutrophils is associated to, does not trigger a
respiratory burst. In fact, we obtained evidence that signals
involved in adhesion and spreading are likely distinct from
those involved in activation of the respiratory burst. As
shown in Fig. 8, anti-CR3 mAbs also trigger neutrophil
spreading. This is in accord with the known adhesion func-
tion of CR3 in neutrophils and activation of CR3 to a mole-
cule able to mediate phagocytosis. As discussed above,
strong evidence has been presented that signals involved in
phagocytosis and activation of the respiratory burst are dis-
tinct (40, 47). Taken together, these observations do suggest
that the a chain of LFA-1 and gp150/95 can interact with sig-
naling molecules involved in activation of respiratory burst.
On the basis of comparison of CR3, LFA-1, and gp150/95 se-
quences, Springer and colleagues pointed out that CR3 and
gp150/95 are more closely related to each other (61%) than
to LFA-1 (35.7 and 37.4%, respectively) (15) . It is, however,
worth noting that the cytoplasmic tail of CR3 is shorter (19
amino acids residues) than that of gp150/95 and LFA-1 (29
and 53 amino acid residues, respectively) . Furthermore, a
short stretch of the cytoplasmic tail of LFA-1 (residues
1,113-1,123) and gp150/95 (residues 1,132-1,144) shows a
high degree ofhomology, with four conserved residues, and
the presence of two serines (LFA-1) and two serines and one
threonine (gp150/95) (see 15) . We believe that the possibility
that these two homologous cytoplasmic domains are in-
volved in the generation of signals by LFA-1 and gp150/95
should be considered.
The evidence that LFA-1 and gp150/95 can activate neutro-
phil respiratory burst may be relevant to understand the
mechanisms underlying the acquirement of the capability to
release toxic oxygen molecule in response to TNF by neutro-
phils adherent to endothelial cells, or serum and extracellu-
lar matrix proteins (16, 22, 24). It has been shown that this
neutrophil response to TNF is strictly dependent on expres-
sion ofleukocyte integrins (24). Experimental systems used
to render neutrophils able to respond to TNF with release
of toxic oxygen molecules require neutrophils adhere to sur-
faces coated with endothelial cells, fibrinogen, fibronectin,
laminin, thrombospondin (22, 24) . Endothelial cells express
ligand for both LFA1 and gp150/95 (19, 36, 37); fibrinogen
is one ofthe ligands for gp150/95 (18). None of the members
of leukocyte integrins are known to recognize other adhesive
Figure 9 niAbs against LFA1 and gp150/95 trigger neutrophil spreading. Glass coverslips were coated with protein A and used to bind:
A, nil (PBS); B, 60.3 ; C, IOM11c; D, IOT16. Bar, 10 /m.
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pacitate neutrophils to respond to TNF. However, studies
with neutrophils of LAD patients demonstrated that also on
these proteins release of toxic oxygen molecules in response
to TNF is strictly dependent on the expression of leukocyte
integrins (24). We therefore believe it is conceivable to sug-
gest that TNF activates LFA-1 and/or gp150/95 to generate
signals responsible for stimulation of neutrophil respiratory
burst. This suggestion is also legitimated by the results of
studies with inhibitors. We observed that activation of the re-
spiratory burst by both anti-CD18 and anti-LFA-1 and
gp150/95 mAbs is suppressed by the microfilaments disrupt-
ing agent cytochalasin B, and by a cAMP analogue. A similar
pattern of sensitivity to cytochalasin B and cAMP analogues
has been observed for the TNF-stimulated respiratory burst
by adherent neutrophils (16, 22, 23).
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